Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy ...
TipRanks on MSN
Microbot Medical initiated with a Buy at Roth Capital
Roth Capital analyst Kyle Bauser initiated coverage of Microbot Medical (MBOT) with a Buy rating and $5.50 price target The firm says the ...
As of Friday, November 28, Microbot Medical Inc.’s MBOT share price has surged by 10.33%, which has investors questioning if ...
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic ...
Microbot Medical says Emory University Hospital in Atlanta is the first worldwide to embrace its Liberty endovascular robotic ...
Microbot Medical Inc. MBOT recently announced that it has entered into an agreement with Emory University, which is likely to allow the entities to evaluate and explore the potential for future ...
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where Microbot Medical Inc (NASDAQ:MBOT) stands ...
We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback